Journey Medical Corporation
DERM
$6.99
-$0.36-4.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -8.73% | -7.59% | -4.24% | -4.37% | -2.95% |
| Total Other Revenue | -94.86% | -94.88% | -100.00% | 5,008.75% | 8,670.72% |
| Total Revenue | -29.69% | -29.11% | -27.69% | 26.38% | 27.82% |
| Cost of Revenue | -16.01% | -12.35% | -29.22% | -27.22% | -22.12% |
| Gross Profit | -35.03% | -35.92% | -26.84% | 74.74% | 70.45% |
| SG&A Expenses | 8.49% | -8.44% | -16.79% | -32.31% | -32.75% |
| Depreciation & Amortization | -2.01% | 12.50% | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -20.52% | -10.63% | -12.60% | -20.49% | -19.40% |
| Operating Income | -1,377.45% | -1,378.22% | -164.11% | 106.33% | 101.50% |
| Income Before Tax | -109.29% | -302.29% | -48.73% | 102.71% | 89.75% |
| Income Tax Expenses | -72.40% | -72.40% | 16.67% | 860.87% | 639.02% |
| Earnings from Continuing Operations | -99.64% | -280.79% | -48.45% | 102.15% | 89.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -99.64% | -280.79% | -48.45% | 102.15% | 89.17% |
| EBIT | -1,377.45% | -1,378.22% | -164.11% | 106.33% | 101.50% |
| EBITDA | -179.84% | -311.97% | -458.55% | 118.45% | 112.80% |
| EPS Basic | -100.61% | -213.31% | -28.41% | 104.55% | 90.98% |
| Normalized Basic EPS | -4,616.95% | -1,479.62% | -80.04% | 105.53% | 99.56% |
| EPS Diluted | -28.39% | -112.33% | -12.19% | 99.29% | 85.64% |
| Normalized Diluted EPS | -260.49% | -382.96% | -48.73% | 99.91% | 94.29% |
| Average Basic Shares Outstanding | 12.80% | 11.90% | 9.76% | 8.01% | 6.04% |
| Average Diluted Shares Outstanding | 8.99% | 8.02% | 5.91% | 11.69% | 9.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |